Market Insight - News

PMR Pharma & Healthcare Insight: Poland

12-month subscription

Product Price

In order to see the price please select your language and the licence

Price:

1 000

After payment your product will be ready to be used.

PMR Pharma & Healthcare Insight: Poland

12-month subscription

Sector: Pharma & Healthcare
Country: Poland

Beside the latest statistics and market news, the PMR weekly focuses particularly on the impact of the coronavirus epidemic on the healthcare market. Subscribers to PMR Pharma & Healthcare Insight receive a weekly summary of the current situation, comprehensive data and statistics from the market affected by the epidemic and revised development scenarios with expert commentary. They can benefit also from PMR graphs and tables on the most currently important issues in the marketplace. This is a unique set of original studies not available anywhere else!

Content

The informations are available through an interactive online platform, provided in the form of weekly updates sent by e-mail. It is possible to create pdf files with the latest news.

As part of your paid subscription to PMR Market Insight, you also receive a monthly comprehensive overview of data and analyses with the most important market statistics.


What is the content of PMR's Insight?

In the PMR weekly magazine you will find continuously updated information on the impact of coronavirus on the sector, including:

  • Analyses of the current situation and development prospects in Poland and abroad in connection with the COVID-19 epidemic
  • Forecasts and indicators that will affect the healthcare market in the coming months, based on data collected by PMR
  • Articles describing strategic solutions and concepts used by industry leaders in response to the changes brought about by the epidemic
  • Current and future trends, possible after the epidemic and key macroeconomic factors
  • Articles showing the expected major events that may affect the healthcare industry.
  • Expert commentaries given by industry leaders, association representatives, economists and PMR’s analysts
  • Articles that offer strategic solutions and ideas from top market performers as well as industry and legal experts articles revealing pharmaceutical market developments, future prospects, emerging trends and important upcoming events that are expected to influence business conditions
  • Commentaries and viewpoints from external and internal specialists

And also:

  • PMR research results combined with explanations by PMR experts
  • Analysis of financial results of selected market players active in the segments of private healthcare, medical devices, drug distributors, drug manufacturers
  • Analyses of the most important mergers and acquisitions transactions influencing the pharma and healthcare market in Poland
  • Legislative changes, the reactions of industry and patient associations
  • Healthcare policy developments with regard to reimbursements and pricing of drugs and patient services
  • National Health Fund, Health Ministry and other governmental actions influencing pharma and healthcare markets
  • Health Technology Assessment Agency recommendations on approval of new medicines and therapies for reimbursement, levels of and conditions required for reimbursement, changes to the list of approved medications
  • Activities of pharmaceutical companies, including major manufacturers and distributors in the areas of wholesale pharmacy and retail chains – their collaborations, new drug registrations, market plans and strategies, financial results
  • Coverage of the research and development (R&D) sector including new project and young company watch insights
  • Public and private healthcare market structure news and analyses, with data on the size of the market, forecasts and number of healthcare facilities based on unique PMR methodology, and local and international investors
  • Epidemiology reports
  • A wide range of macroeconomic and industry-related statistics, data, indicators and dashboardsArchive of articles and data for the sector. 
Benefits

What distinguishes PMR Insight?

  • Cyclical monitoring of the healthcare market and its development potential with regard to changes related to the coronavirus epidemic in Poland, carried out by analysts with many years of experience who know the specifics of the analysed sector
  • The articles published in the PMR Insight week are proprietary materials, not available elsewhere.
  • Current access to all key statistics collected in one place, with an explanation
  • Access not only to historical data, but also to estimates for the coming year, based on the knowledge and experience of analysts
  • Presentation of the most important conclusions from primary research conducted by PMR for the purposes of healthcare reports.

Why it’s worth it to buy the PMR Insight weekly magazine?

  • To gain access to a broad range of market intelligence content for the pharmaceutical and healthcare market in Poland in order to recognise market trends, evaluate new business opportunities, build successful strategies and analyse competition
  • To keep your business up-to-date with the latest market news
  • To benefit from very often unique information that cannot be found in any other source of information about the pharmaceutical and healthcare market in Poland
  • To take advantage of experience of our market analysts who share with you their views and present in-depth analyses
  • To have a regular access to current and archived market statistics which allow your own analyses and comparisons based on the verified data
Users

Who benefits from the PMR's Insight?

  • Executives at leading regional and international pharmaceutical, medical, insurance and consulting companies
  • Professionals at firms that manufacture and distribute medical supplies
  • Foreign investors in the Polish pharmaceutical and medical market
  • Government agencies
  • Pharmaceutical and healthcare industry professional organisations
  • Banks, brokerage firms and other financial institutions with an interest in pharma and healthcare market performance.

 

Request FREE Trial!

Request Free Trial and get immediate access to set of the latest news & insights:
PMR Pharma & Healthcare Insight: Poland

REQUEST TRIAL

Product Price

In order to see the price please select your language and the licence

Price:

1 000

After payment your product will be ready to be used.

Sector: Pharma & Healthcare
Country: Poland

Each licence option entitles Client to make use of the product within the following limits/ number of users:

Standard – up to 2 users

Standard Plus – between 3 and 9 users

Corporate – from 10 unique users and more

For more information please visit: mypmr.pro/terms-and-conditions

This content is available for current PMR clients. If you are a client please log-in or contact us for more information at: +48 12 340 51 30.

Jest to zawartość dostępna dla obecnych klientów PMR. Jeśli jesteś klientem, zaloguj się lub skontaktuj się z nami, aby uzyskać więcej informacji: +48 12 340 51 30.